Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowFebruary 13, 2025 — 3:45 PM - 4:15 PM ET
Nasdaq MarketSite, 4 Times Square, New York
Aardvark Therapeutics, Inc. (Nasdaq: AARD), a clinical-stage biopharmaceutical company developing novel, small molecule therapeutics for the treatment of metabolic disease visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Tien Lee, M.D., CEO & Founder, rings the Closing Bell.
